Beylerli, Ozal,
Gareev, Ilgiz,
Musaev, Elmar,
Roumiantsev, Sergey,
Chekhonin, Vladimir,
Ahmad, Aamir,
Chao, Yuan,
Yang, Guang (2025) -tumor barrier (BTB), which limit the efficacy of systemic
therapies. Recent advances in
molecular biology
. Glioblastoma (GBM), a grade IV brain tumor, is known for its heterogeneity and resistance to
therapy. Modern
Gareev, Ilgiz,
Beylerli, Ozal,
Tamrazov, Rasim,
Ilyasova, Tatiana,
Shumadalova, Alina,
Du, Weijie,
Yang, Baofeng (2023) effectively
target various structures within the central nervous system (CNS). MiRNA-based
therapy stands out
BEYLERLI, OZAL,
BEERAKA, NARASIMHA M.,
GAREEV, ILGIZ,
PAVLOV, VALENTIN,
YANG, GUANG,
LIANG, YANCHAO,
ALIEV, GJUMRAKCH (2020) single-stranded RNA molecules that can influence post-transcriptional regulation by controlling
targetBegliarzade, Sema,
Sufianov, Albert,
Ilyasova, Tatiana,
Shumadalova, Alina,
Sufianov, Rinat,
Beylerli, Ozal,
Yan, Zhongrui (2024) research to uncover the underlying
molecular mechanisms of CC and to discover novel diagnostic
to elevated morbidity and mortality. Despite their prevalence, the underlying
molecular mechanisms governing
Begliarzade, Sema,
Beilerli, Aferin,
Sufianov, Albert,
Tamrazov, Rasim,
Kudriashov, Valentin,
Ilyasova, Tatiana,
Liang, Yanchao,
Beylerli, Ozal (2023) tools, as well as to consider them as effective
therapeutic
targets in cervical cancer.
for comprehensive clinical trials to establish the efficacy of polyphenol-based
therapies targeting nc
of global death. The purpose of our bioinformatics analysis was to detect viable pathophysiological
targetsBeylerli, Ozal,
Ju, Jiaming,
Beilerli, Aferin,
Gareev, Ilgiz,
Shumadalova, Alina,
Ilyasova, Tatiana,
Bai, Yunlong,
Yang, Baofeng (2023) RNAs that play key roles in structural and electrical remodeling may become
molecular markers and
targets for AF